Medical Health & Life Science Research News

Detailed examination of the global rapid influenza diagnostic tests market forecast to 2027

Detailed examination of the global rapid influenza diagnostic tests market forecast to 2027

Technavio Announces the Publication of its Research Report – Global Rapid Influenza Diagnostic Tests Market 2017-2021

- Advertisement -
- Market Research Pro -

Technavio recognizes the following companies as the key players in the global rapid influenza diagnostic tests market: Alere, BD, and Quidel.Other Prominent Vendors in the market are: bioMérieux, CorisBioconcept, Meridian Bioscience, Response Biomedical, Princeton BioMeditech Corporation, SA Scientific, Sekisui Diagnostics, and Thermo Fisher Scientific.Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is rising technological advancements in diagnostics. The current healthcare market is shifting toward novel technology based, cost-effective devices in the diagnostic industry.

There is an increasing number of manufacturers focusing on developing new-generation POC influenza tests such as LoC/microchip technology based on microelectromechanical system (MEMS). This technology mainly focusses on biological and chemical applications.”

Request Sample of Report at marketreportscenter.com/request-sample/554637

According to the report, one driver in the market is government initiatives to control and prevent influenza.

- Advertisement -
- Market Research Pro -

Pandemic influenza poses a risk of human health. For instance, the recent emergence of influenza A (H1N1) virus had led to a global influenza pandemic.

As a result, there is increased requirement for diagnostic tests for influenza globally. Sophisticated influenza tests are available only in specialized laboratories.

However, at the time of pandemic, their capacity may be overwhelming. Hence the use of RIDTs is preferred, especially in a remote setting without laboratory services.

The RIDTs can be performed by healthcare professionals and test result can be obtained within 15-30 minutes.Further, the report states that one challenge in the market is product safety features of the test kits. Product safety features of any diagnostic tests are highly recommended to measure the efficacy and acceptability of a product.

The product safety features ensure that the product is suitable for the consumers. Also, it ensures guarantee to the consumers that they are compliant with international standards.

The regulatory organizations dealing with testing of the product features entitle the manufacturers to display specific mark accepted in particular country. For instance, there is Warnock Hersey (WH) and Normas Oficiales Mexicanas (NOM) mark in the US and Mexico, and GS and ASTA mark in Europe.

Access Report at marketreportscenter.com/request-discount/554637

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.About Rapid Influenza Diagnostic TestsRIDT is an antigen-based diagnostic test used for diagnosis of influenza virus infections in point-of-care (POC) settings.

It employs lateral flow technique called immunochromatographic assays. RIDTs are available in the market in the form of a dipstick, card, and cassette.

The instrument completes the test in less than 30 minutes and is commonly used for the diagnosis of influenza infections. Based on product type, global RIDTs market is segmented into RIDTs for influenza A and RIDTs for influenza B.Technavio’s analysts forecast the global rapid influenza diagnostic tests market to grow at a CAGR of 9.06% during the period 2017-2021.Covered in this report
The report covers the present scenario and the growth prospects of the global rapid influenza diagnostic tests market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of RIDTs.The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEATechnavio's report, Global Rapid Influenza Diagnostic Tests Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a discussion of the key vendors operating in this market.

Know more about report at marketreportscenter.com/reports/55…-market-2017-2021

Key vendors
• Alere
• BD
• QuidelOther prominent vendors
• bioMérieux
• CorisBioconcept
• Meridian Bioscience
• Response Biomedical (acquired by OrbiMed)
• Princeton BioMeditech Corporation
• SA Scientific
• Sekisui Diagnostics
• Thermo Fisher ScientificMarket driver
• Government initiatives to control and prevent influenza
• For a full, detailed list, view our report Market challenge
• Product safety features of the test kits
• For a full, detailed list, view our report Market trend
• Rising technological advancements in diagnostics
• For a full, detailed list, view our report Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

News From

Market Reports Center - One Stop Shop for all market research needsMarket Reports Center
Category: Market Research Publishers and RetailersCompany profile: Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable. Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals ...